Right now, we are on track.
After your first injection, you will continue to take semaglutide GLP-1 once a week, ideally on the same day each week
Route of Administration Analysis Injectable anti-obesity drugs was the leading segment with 75.9% revenue share in 2024, primarily due to their superior efficacy and sustained weight loss results compared to other administration routes
A 42-year-old female with longstanding profound fatigue, chronic pain, asthma, multiple food intolerances, GI symptoms including diarrhea, urticaria, food cravings, weight gain, and migraine who was essentially housebound due to constant exhaustion (she estimated 30% of normal energy) took tirzepitide at 3.75 mg principally to address obesity